During 2018, the World Health Organization released new recommendations on human rabies prophylaxis, based in part upon information supplied by the Strategic Advisory Group of Experts (SAGE) group. This free webinar is an opportunity for global biomedical professionals to learn about these current guidelines, acquire up-to-date information about novel rabies biologics, regimens and routes, and understand various disease prevention aspects from a clinical, local, national, public health, regulatory and scientific perspective. Audience participation, both in attendance at the RITA Conference and connecting remotely, is encouraged.
https://register.gotowebinar.com/register/8874099375573675020
Questions or Comments? Contact: pcosta@onehealthcommission.org
Agenda
- 9:00 Welcome & Opening Comments – Moderator, Dr. Charles E. Rupprecht, LYSSA LLC
- 9:10 The 2018 WHO/SAGE Position on Human Rabies Prophylaxis – Dr. Lea Knopf, World Health Organization
- 9:30 Updating the Advisory Committee on Immunization Practice Recommendations for Prevention of Human Rabies–United States 2018-present – Dr. Agam K. Rao, Centers for Disease Control and Prevention, United States
- 9:50 Interpretation of International and National Guidelines on Human Rabies Prophylaxis by Clinicians – Dr. Stephen Scholand, Rabies Free World
- 10:10 Break
- 10:30 Regulatory Considerations for Current and Future Rabies Virus Biological Products – Dr. Robin Levis, Food and Drug Administration, United States
- 10:50 Immune Responses to Conventional and Experimental Rabies Vaccines – Dr. Gundi Ertl, The Wistar Institute
- 11:10 New Human Rabies Biologics on the Horizon? – Dr. Lorraine McElhinney, Animal and Plant Health Agency, United Kingdom
- 11:30 Moderated group discussion and audience participation
- Noon-12:30 Finish